MDT

87.92

-0.94%↓

A

115.46

-1.22%↓

VEEV

157.06

-5.63%↓

HQY

83.88

+2.36%↑

TLRY

6.71

-0.3%↓

MDT

87.92

-0.94%↓

A

115.46

-1.22%↓

VEEV

157.06

-5.63%↓

HQY

83.88

+2.36%↑

TLRY

6.71

-0.3%↓

MDT

87.92

-0.94%↓

A

115.46

-1.22%↓

VEEV

157.06

-5.63%↓

HQY

83.88

+2.36%↑

TLRY

6.71

-0.3%↓

MDT

87.92

-0.94%↓

A

115.46

-1.22%↓

VEEV

157.06

-5.63%↓

HQY

83.88

+2.36%↑

TLRY

6.71

-0.3%↓

MDT

87.92

-0.94%↓

A

115.46

-1.22%↓

VEEV

157.06

-5.63%↓

HQY

83.88

+2.36%↑

TLRY

6.71

-0.3%↓

Home・Aandelen Lijst・Lyell Immunopharma Inc

Search

Lyell Immunopharma Inc

Gesloten

23.87 4.01

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

21.01

Max

23.92

Belangrijke statistieken
By Trading Economics
Inkomsten	-102M -141M
Verkoop	-9K 6K
EPS	-7.68
Winstmarge	-2,345,383.333
Werknemers	300
EBITDA	-23M -59M

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+81.36% upside

Dividenden
By Dow Jones
Volgende Winsten	11 mei 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-36M 506M
Vorige openingsprijs	19.86
Vorige sluitingsprijs	23.87

Technische score

By Trading Central

Vertrouwen

Strong Bearish Evidence

0.4217 / 0.4691 Steun & Weerstand

Lyell Immunopharma Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

8 apr 2026, 20:44 UTC

Winsten

Costco Reports 11% Growth in March Sales

8 apr 2026, 23:51 UTC

Marktinformatie

Global Equities Roundup: Market Talk

8 apr 2026, 23:51 UTC

Marktinformatie

Nikkei May Rise on Hopes for Talks to End Iran War -- Market Talk

8 apr 2026, 23:36 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Gold Edges Lower on Likely Technical Correction -- Market Talk

8 apr 2026, 22:56 UTC

Marktinformatie

Ramelius Resources May Downgrade Cost Guidance This Month -- Market Talk

8 apr 2026, 22:45 UTC

Marktinformatie

Constellation Brands Points to Continuing Challenges Among Hispanic Consumers -- Market Talk

8 apr 2026, 22:17 UTC

Marktinformatie

Applied Digital Says Its Holding Out for Quality Customers -- Market Talk

8 apr 2026, 21:52 UTC

Belangrijke Nieuwsgebeurtenissen

A Closer Look at Iran's 10 Demands -- and Which the U.S. Might Accept -- Update

8 apr 2026, 21:24 UTC

Winsten

FedEx Freight Aims for 12% Profit Growth. How That Compares to the Leader. -- Barrons.com

8 apr 2026, 21:01 UTC

Belangrijke Nieuwsgebeurtenissen

Oil Prices Tumble Despite Conflicting Reports About the Strait of Hormuz -- Barrons.com

8 apr 2026, 20:50 UTC

Marktinformatie

Energy & Utilities Roundup: Market Talk

8 apr 2026, 20:43 UTC

Acquisities, Fusies, Overnames

Oracle Is Expressing No Opinion and Is Neutral as to Whether Stockholders Should Tender Their Shrs in Response to TRC's Offer >ORCL

8 apr 2026, 20:43 UTC

Acquisities, Fusies, Overnames

Oracle Does Not Endorse TRC's Mini-Tender Offer or the Offer Documentation >ORCL

8 apr 2026, 20:43 UTC

Acquisities, Fusies, Overnames

Oracle: Offer Represents Less Than 0.04% of Outstanding Common Stk >ORCL

8 apr 2026, 20:42 UTC

Acquisities, Fusies, Overnames

Oracle: TRC Offer Is to Purchase Up to 1M Shrs of Common Stk at $140.50/Shr in Cash >ORCL

8 apr 2026, 20:42 UTC

Acquisities, Fusies, Overnames

Oracle Received Notice of Unsolicited Mini-Tender Offer by TRC Dated March 24 >ORCL

8 apr 2026, 20:42 UTC

Acquisities, Fusies, Overnames

Oracle Responds to TRC Cap Mini-Tender Offer

8 apr 2026, 20:15 UTC

Marktinformatie

Global Commodities Roundup: Market Talk

8 apr 2026, 20:11 UTC

Acquisities, Fusies, Overnames

Intel Corp.: Repurchased 49% Equity Interest in JV Related to Intel's Fab 34 in Ireland >INTC

8 apr 2026, 20:11 UTC

Acquisities, Fusies, Overnames

Intel Corp.: $14.2B Repurchase Price Financed with Cash on Hand and a Bridge Loan of $6.5B >INTC

8 apr 2026, 20:11 UTC

Acquisities, Fusies, Overnames

Intel Corp.: Repurchased JV Stake From Apollo-Managed Funds and Affiliates >INTC

8 apr 2026, 19:44 UTC

Winsten

These Companies Pay 5% Dividend Yields, and They're Hiking Them Too -- Barrons.com

8 apr 2026, 19:16 UTC

Marktinformatie

Hogs Follow Cutout Prices Lower -- Market Talk

8 apr 2026, 19:02 UTC

Marktinformatie

Global Energy Roundup: Market Talk

8 apr 2026, 19:02 UTC

Marktinformatie

Oil Futures Plunge as Cease-Fire Raises Hopes for Restored Supply -- Market Talk

8 apr 2026, 18:58 UTC

Marktinformatie

U.S. Natural Gas Futures Fall in Line With Slump in Oil -- Market Talk

8 apr 2026, 18:51 UTC

Marktinformatie

Global Equities Roundup: Market Talk

8 apr 2026, 18:51 UTC

Marktinformatie

Levi Strauss CEO Says Expanded Offerings, DTC Focus Are Working -- Market Talk

8 apr 2026, 18:14 UTC

Belangrijke Nieuwsgebeurtenissen

Fed Minutes Suggest a Lengthy Iran War Could Lead to Rate Hikes -- Barrons.com

8 apr 2026, 18:05 UTC

Belangrijke Nieuwsgebeurtenissen

Oil Prices Continue to Tumble After Cease-Fire Despite Slow Reopening of Strait of Hormuz -- Barrons.com

Peer Vergelijking

Prijswijziging

Lyell Immunopharma Inc Prognose

Koersdoel

By TipRanks

81.36% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 39.5 USD 81.36%

Hoogste 45 USD

Laagste 34 USD

Gebaseerd op 2 Wall Street-analisten die 12-maands prijsdoelen bieden voor Lyell Immunopharma Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

2 ratings

2

Buy

0

Hold

0

Sell

Gebaseerd op 2 analisten die aandelenratings hebben gegeven aan Lyell Immunopharma Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

0.4217 / 0.4691Steun & Weerstand

Recent bearish events outweigh bullish events.

There is one bearish event.

There are no events.

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Andere aandelen uit de sector

MDT

Medtronic PLC

87.92

A

Agilent Technologies Inc

115.46

VEEV

Veeva Systems Inc

157.06

HQY

HealthEquity Inc

83.88

TLRY

Tilray Brands Inc

6.71

Live chat